<DOC>
	<DOCNO>NCT01177410</DOCNO>
	<brief_summary>The purpose study determine daily dose mesalamine granule provide adequate relief symptom IBS diarrhea .</brief_summary>
	<brief_title>Mesalamine Granules Irritable Bowel Syndrome ( IBS ) With Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Male nonpregnant , nonlactating female subject Diagnosed IBS confirm Rome III criterion Meet follow IBS symptom score category diary eligibility period : An average daily score great equal 3 abdominal pain An average daily score great equal 3 bloat An average daily score 5 great stool consistency use Bristol Stool Scale Does adequate relief IBS symptom ( weekly report ) past 7 day first day screen day randomization Present hard lumpy stool ( Type 1 Type 2 ) Bristol Stool form Scale diary eligibility period history inflammatory bowel disease Type 1 2 diabetes pregnant lactate history HIV hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>IBS</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>IBS-D</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Abdominal pain</keyword>
	<keyword>Bloating</keyword>
</DOC>